Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV

AIDS and Behavior

Volumn 16, Issue 8, 2012, Pages 2286-2296

  Patton, Doyle E ^a   Woods, Steven Paul ^b,c   Franklin Jr , Donald ^b   Cattie, Jordan E ^d   Heaton, Robert K ^b   Collier, Ann C ^e   Marra, Christina ^e   Clifford, David ^f   Gelman, Benjamin ^g   McArthur, Justin ^h   Morgello, Susan ⁱ   Simpson, Susan ⁱ   McCutchan, J Allen ^b   Grant, Igor ^b  

^a Children's Diagnostic and Treatment Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN DIEGO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; Construct validity; HIV; Instrumental activities of daily living; Medication management; Neuropsychological functioning

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATIENT COMPLIANCE; PREDICTIVE VALUE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEX RATIO; SOCIOECONOMICS; TASK PERFORMANCE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTI-RETROVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; TASK PERFORMANCE AND ANALYSIS; YOUNG ADULT;

EID: 84868588464     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0237-7     Document Type: Article

References (41)

1. Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS. 2004;18(Suppl 1):S75-8.
2. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3-16.
3. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8:136-42.
4. Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21:1915-21.
5. Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIVassociated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317-31.
6. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789-99.
7. Blackstone K, Moore DJ, Franklin DR, et al. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012;18(1):79-88.
8. Albert SM, Weber CM, Todak G, et al. An observed performance test of medication management ability in HIV: relation to neuropsychological status and medication outcomes. AIDS Behav. 1999;3:121-8.
9. Albert SM, Flater SR, Clouse R, et al. Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy. AIDS Behav. 2003;7(3):329-38.
10. Benedict RH, Mezhir JJ, Walsh K, Hewitt RG. Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol. 2000;15(6):535-44.
11. Waldrop-Valverde D, Jones DL, Jayaweera D, Gonzalez P, Romero J, Ownby RL. Gender differences in medication management capacity in HIV infection: the role of health literacy and numeracy. AIDS Behav. 2009;13(1):46-52.
12. Woods SP, Moran LM, Carey CL, et al. Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23:257-70.
13. Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944-50.
14. Woods SP, Dawson MS, Weber E, et al. Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Intl Neuropsycholl Soc. 2009;15:42-52.
15. World Health Organization. Priority Interventions HIV/AIDS prevention, treatment and care in the health sector. Geneva: WHO; 2010.
16. Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav. 2010;14(6):1213-26.
17. Ettenhofer ML, Foley J, Castellon SA, Hinkin CH. Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology. 2010;74(15):1217-22.
18. Diehl M, Willis SL, Schaie KW. Everyday problem solving in older adults: observational assessment and cognitive correlates. Psychol Aging. 1995;10(3):478-91.
19. Waldrop-Valverde D, Osborn CY, Rodriguez A, Rothman RL, Kumar M, Jones D. Numeracy skills explain racial differences in HIV medication management. AIDS Behav. 2010;14(4):799-806.
20. Waldrop-Valverde D, Jones DL, Gould F, Kumar M, Ownby RL. Neurocognition, health-related reading literacy, and numeracy in medication management for HIV infection. AIDS Patient Care STDS. 2010;24(8):477-84.
21. Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Odessa: Psychological Assessment Resources; 2004.
22. Thames AD, Kim MS, Becker BW, et al. Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol. 2011;33(2):200-9.
23. Heaton RK, Clifford DB, Woods SP, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology. 2010;75:2087-96.
24. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12:255-66.
25. Wilkinson GS. Wide Range Achievement Test. 3rd ed. Wilmington: Wide Range; 1993.
26. Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz: Psychological Assessment Resources, Inc; 2004
27. Heaton RK, Taylor MJ, Manly JJ. Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In: Tulsky D, et al., editors. Clinical interpretation of the WAIS-III and WMS-III. San Diego: Academic Press; 2002. p. 183-210.
28. Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin card sorting test-64 card version: professional manual. Lutz: Psychological Assessment Resources Inc.; 2000.
29. Reitan RM. Manual for administration of neuropsychological test batteries for adults and children. Tucson: Reitan Neuropsychology Laboratories, Inc.; 1979.
30. Corporation Psychological. WAIS-III and WMS-III technical manual. San Antonio: Author; 1997.
31. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exper Neuropsychol. 2004;26:759-78.
32. Valpar International Corporation. Computerized assessment (COMPASS). Tucson: Author; 1992.
33. U.S. Department of Labor. Dictionary of occupational titles. 4th ed. Washington: U.S. Government Printing Office; 1991.
34. Janikowski TP, Bordieri JE, Musgrave Jr. Construct validation of the academic achievement and general educational development subtests of the microcomputer evaluation screening and assessment (MESA). Voc Eval Work Adjust Bull. 1990;23:11-6.
35. Stoelting C. A study of the construct validity of the MESA. Voc Eval Work Adjust Bull. 1990;23:85-91.
36. World Health Organization. Composite international diagnostic interview, version 2.1. Geneva: WHO; 1997.
37. Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory-II. San Antonio: Psychological Corporation; 1996.
38. Basso MR, Bornstein RA. Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12-months. J Clin Exper Neuropsychol. 2000;22: 208-18.
39. Satz P, Morgenstern H, Miller EN, et al. Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the multicenter AIDS cohort study (MACS). J Acquir Immune Defic Syndr. 1993;66(5):503-11.
40. Pereda M, Ayuso-Mateos JL, Gomez Del Barrio A, et al. Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychol Med. 2000;30:205-17.
41. Waldrop-Valverde D, Jones DL, Weiss S, Kumar M, Metsch L. The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users. AIDS Care. 2008;20(10):1202-10.